US Stock MarketDetailed Quotes
BLPH Bellerophon Therapeutics
- 0.055
- +0.001+1.66%
15min DelayClose Apr 25 16:00 ET
672.80KMarket Cap-61P/E (TTM)
0.055High0.055Low10.14KVolume0.055Open0.054Pre Close557.42Turnover0.09%Turnover RatioLossP/E (Static)12.23MShares11.15052wk High0.18P/B654.87KFloat Cap0.02952wk Low--Dividend TTM11.91MShs Float193.800Historical High--Div YieldTTM0.92%Amplitude0.029Historical Low0.054Avg Price1Lot Size
Bellerophon Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -26.39%-6.33M | -34.01%-4.92M | 168.96%3.27M | 22.13%-17.77M | -9.40%-4.35M | 10.31%-5.01M | 31.63%-3.67M | 39.94%-4.74M | -14.77%-22.82M | 37.88%-3.98M |
| Net income from continuing operations | 62.10%-1.92M | -25.16%-5.14M | 150.03%2.82M | -11.69%-19.83M | -17.42%-5.02M | -9.39%-5.07M | -21.13%-4.11M | -3.30%-5.64M | 28.19%-17.76M | 46.63%-4.27M |
| Operating gains losses | ---- | ---- | ---- | 99.83%-1K | ---- | ---- | ---- | ---- | -283.49%-600K | --0 |
| Depreciation and amortization | --0 | -94.74%1K | -95.24%1K | -36.27%65K | -80.95%4K | -12.50%21K | -32.14%19K | -27.59%21K | -30.61%102K | -27.59%21K |
| Change In working capital | -2,297.77%-4.29M | -58.29%83K | -74.13%179K | 121.27%1.21M | 188.44%499K | 84.26%-179K | 108.54%199K | 128.86%692K | -333.61%-5.69M | -87.01%173K |
| -Change in prepaid assets | 191.36%74K | -336.54%-369K | -80.68%40K | 293.00%386K | -62.59%104K | -912.50%-81K | 135.14%156K | 896.15%207K | -1,233.33%-200K | 30.52%278K |
| -Change in payables and accrued expense | -4,355.10%-4.37M | 518.60%266K | -71.34%139K | 115.02%825K | 476.19%395K | 91.32%-98K | 102.28%43K | 120.45%485K | -324.02%-5.49M | -109.38%-105K |
| -Change in other current assets | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -26.39%-6.33M | -34.01%-4.92M | 168.96%3.27M | 22.13%-17.77M | -9.40%-4.35M | 10.31%-5.01M | 31.63%-3.67M | 39.94%-4.74M | -14.77%-22.82M | 37.88%-3.98M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 26K | 4.98M | -40K | -40K | 0 | 0 | 0 | 0 | |
| Net common stock issuance | --0 | --0 | --1.44M | --0 | --0 | --0 | --0 | --0 | --0 | ---- |
| Proceeds from stock option exercised by employees | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --0 | ---- |
| Net other financing activities | --0 | ---3.55M | --3.55M | ---40K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --26K | --4.98M | ---40K | ---40K | --0 | --0 | --0 | --0 | ---- |
| Net cash flow | ||||||||||
| Beginning cash position | -36.15%10.68M | -23.65%15.58M | -70.85%7.33M | -47.58%25.14M | -59.75%11.72M | -51.79%16.73M | -49.09%20.4M | -47.58%25.14M | 366.67%47.96M | -46.45%29.12M |
| Current changes in cash | -23.59%-6.19M | -33.31%-4.9M | 274.16%8.25M | 21.96%-17.81M | -10.41%-4.39M | 10.31%-5.01M | 31.63%-3.67M | 39.94%-4.74M | -160.56%-22.82M | 37.97%-3.98M |
| End cash Position | -61.69%4.49M | -36.15%10.68M | -23.65%15.58M | -70.85%7.33M | -70.85%7.33M | -59.75%11.72M | -51.79%16.73M | -49.09%20.4M | -47.58%25.14M | -47.58%25.14M |
| Free cash flow | -26.39%-6.33M | -34.01%-4.92M | 168.96%3.27M | 22.13%-17.77M | -9.40%-4.35M | 10.31%-5.01M | 31.63%-3.67M | 39.94%-4.74M | -14.77%-22.82M | 37.88%-3.98M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg